DMAC Stock-Based Compensation
Diamedica Therapeutics Inc · Stock-Based Compensation
DMAC Stock-Based Compensation
Latest reported$3.13Mperiod ending
DMAC TTM Stock-Based Comp ($0.00 → $3.13M)
TTM stock-based compensation
High-resolution chart · PNG
DMAC stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 3,132,000 | |
| 2,785,000 | |
| 2,830,000 | |
| 2,227,000 | |
| 2,792,000 | |
| 2,464,000 | |
| 2,085,000 | |
| 1,952,000 | |
| 1,812,000 | |
| 1,749,000 | |
| 1,683,000 | |
| 1,638,000 | |
| 1,631,000 | |
| 1,616,000 | |
| 1,502,000 | |
| 1,389,000 | |
| 1,274,000 | |
| 1,355,000 | |
| 1,558,000 | |
| 1,766,000 | |
| 1,971,000 | |
| 1,961,000 | |
| 1,843,000 | |
| 1,738,000 | |
| 1,681,000 | |
| 1,427,000 | |
| 1,164,000 | |
| 691,177 | |
| 350,177 | |
| 460,177 | |
| 483,177 | |
| 701,917 | |
| 741,625 | |
| 516,643 | |
| 409,000 | |
| 344,543 | |
| 233,984 | |
| 228,857 | |
| 258,832 | |
| 263,207 | |
| 175,850 | |
| 157,677 | |
| 125,486 | |
| 89,653 | |
| 320,993 | |
| 281,076 | |
| 343,301 | |
| 412,794 | |
| 431,634 | |
| 666,196 | |
| 704,571 | |
| 804,306 | |
| 832,895 | |
| 971,939 | |
| 1,032,070 | |
| 811,840 | |
| 852,740 | |
| 637,615 | |
| 615,964 | |
| 855,512 | |
| 608,418 | |
| 476,083 | |
| 294,485 | |
| 64,364 | |
| 84,475 | |
| 178,609 | |
| 252,397 | |
| 242,970 | |
| 220,119 | |
| 96,038 | |
| 21,627 | |
| 21,627 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |